- Pancreatic cancer pill that doubled survival may get Canada clinical trial Global News
- Canadian pancreatic cancer specialist expects to open clinical trials on pill that doubled survival time CTV News
- Breakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an ‘undruggable’ disease The Conversation
- ‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long The Washington Post
- Daily pill can double survival time for world’s deadliest cancer, trial shows | Pancreas cancer The Guardian
Add Comment